Suppr超能文献

载曲酸胶原-壳聚糖纳米粒子作为皮肤美白产品的研制:体外和体内评价。

Development of kojic acid loaded collagen-chitosan nanoparticle as skin lightener product: in vitro and in vivo assessment.

机构信息

Pharmaceutical Sciences Research Centre, Heamoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

J Biomater Sci Polym Ed. 2024 Jan;35(1):63-84. doi: 10.1080/09205063.2023.2268316. Epub 2024 Jan 2.

Abstract

In the present study, an ionic gelation and ultrasonic approach was performed to produce kojic acid (KA) loaded chitosan(CS)/collagen(CN) nanoparticle(NP) (CSCN-NP) which aimed to increase the dermal delivery and anti-pigmentation effect. To optimize the CSCN-NP the effect of the amount of CN was investigated. The results showed that increasing CN from 0 to 500 mg increased the mean particle size and entrapment efficiency of KA-CSCN-NP from 266.07 ± 9.30 nm to 404.23 ± 9.44 nm and 17.37 ± 2.06% to 82.34 ± 2.16%, respectively. Differential scanning calorimetry confirmed the amorphous form of KA in CSCN-NP, while scanning electron microscopy revealed that the nanoparticles were spherical. There was no chemical interaction between KA and the other components base on attenuated total reflectance-Fourier transform infrared spectroscopy. The skin permeability test showed that KA-CSCN-NP gel delivered more KA to the dermal layers (29.16 ± 1.67% or 537.26 ± 537.26 μg/cm) and receiver compartment (15.04 ± 1.47% or 277.15 ± 27.22 μg/cm) compared to KA plain gel. cytotoxicity assay demonstrated that the improved KA-CSCN-NP was non-toxic. Dermal irritating test on Wistar rats showed that the KA gel was non-irritating. Furthermore, KA-CSCN-NP was found to inhibit melanin formation to a greater extent than free KA and significantly inhibited L-dopa auto-oxidation (94.80 ± 2.41%) compared to pure kojic acid solution (75.28 ± 3.22%). The observations of this study revealed that the produced KA-CSCN-NP might be used as a potential nano-vehicle for KA dermal administration, thereby opening up innovative options for the management of hyper-melanogenesis problems.

摘要

在本研究中,采用离子凝胶化和超声法制备了曲酸(KA)负载壳聚糖(CS)/胶原蛋白(CN)纳米粒(CSCN-NP),旨在增加透皮递送和抗色素沉着效果。为了优化 CSCN-NP,考察了 CN 用量的影响。结果表明,随着 CN 从 0 增加到 500mg,KA-CSCN-NP 的平均粒径和包封效率从 266.07±9.30nm 增加到 404.23±9.44nm 和 17.37±2.06%增加到 82.34±2.16%。差示扫描量热法证实 KA 在 CSCN-NP 中呈无定形形式,而扫描电子显微镜显示纳米粒为球形。基于衰减全反射-傅里叶变换红外光谱,KA 与其他成分之间没有化学相互作用。皮肤渗透试验表明,KA-CSCN-NP 凝胶向真皮层(29.16±1.67%或 537.26±537.26μg/cm)和接受室(15.04±1.47%或 277.15±27.22μg/cm)递送更多的 KA。细胞毒性试验表明,改良的 KA-CSCN-NP 无毒性。Wistar 大鼠皮肤刺激性试验表明,KA 凝胶无刺激性。此外,与游离 KA 相比,KA-CSCN-NP 对黑色素形成的抑制作用更大,并显著抑制 L-多巴自动氧化(94.80±2.41%),而与纯曲酸溶液(75.28±3.22%)相比。本研究的观察结果表明,所制备的 KA-CSCN-NP 可用作 KA 经皮给药的潜在纳米载体,为解决黑素生成过度问题提供了新的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验